Oncology and Hematology

273-288 of 612

Optimizing Quality of Life in HER2+ Metastatic Breast Cancer
Optimizing Quality of Life in HER2+ Metastatic Breast Cancer
On the Frontlines of Metastatic Breast Cancer
Optimizing Quality of Life in HER2+ Metastatic Breast Cancer
- Megan Kruse, MD
Refining First-Line Therapy in Advanced Endometrial Care: LEAP-001 Trial Results
Refining First-Line Therapy in Advanced Endometrial Care: LEAP-001 Trial Results
Project Oncology®
Refining First-Line Therapy in Advanced Endometrial Care: LEAP-001 Trial Results
Recognizing and Addressing Rheumatic irAEs from Cancer Immunotherapies
Recognizing and Addressing Rheumatic irAEs from Cancer Immunotherapies
Global Oncology Academy
Recognizing and Addressing Rheumatic irAEs from Cancer Immunotherapies
- Laura Cappelli, MD, MHS,MS
Oral Contraceptives and Endometrial Cancer: Examining a Potential Dose-Response Protective Effect
Oral Contraceptives and Endometrial Cancer: Examining a Potential Dose-Response Protective Effect
Project Oncology®
Oral Contraceptives and Endometrial Cancer: Examining a Potential Dose-Response Protective Effect
Prostate Cancer and Cannabis Use: Exploring Results From a Case-Control Study
Prostate Cancer and Cannabis Use: Exploring Results From a Case-Control Study
Clinician's Roundtable
Prostate Cancer and Cannabis Use: Exploring Results From a Case-Control Study
- Ihtisham Ahmad
Colorectal Cancer Screening: Evaluating the Cost-Effectiveness of Noninvasive Options
Colorectal Cancer Screening: Evaluating the Cost-Effectiveness of Noninvasive Options
Clinician's Roundtable
Colorectal Cancer Screening: Evaluating the Cost-Effectiveness of Noninvasive Options
- Brian P. McDonough, MD, FAAFP
- Carolyn Rutter, PhD
- Gloria Coronado, PhD
Cost Considerations for Colorectal Cancer Screening: Examining the Data
Cost Considerations for Colorectal Cancer Screening: Examining the Data
Clinician's Roundtable
Cost Considerations for Colorectal Cancer Screening: Examining the Data
Balancing Efficacy and Tolerability in Metastatic Breast Cancer Treatment
Balancing Efficacy and Tolerability in Metastatic Breast Cancer Treatment
On the Frontlines of Metastatic Breast Cancer
Balancing Efficacy and Tolerability in Metastatic Breast Cancer Treatment
- Paolo Tarantino, MD
Addressing Barriers to Colorectal Cancer Screening in Rural Populations
Addressing Barriers to Colorectal Cancer Screening in Rural Populations
Clinician's Roundtable
Addressing Barriers to Colorectal Cancer Screening in Rural Populations
- Peter Buch, MD, FACG, AGAF, FACP
- Michael Dougherty, MD
Navigating Metastatic Breast Cancer Care: Key Factors in Decision-Making
Navigating Metastatic Breast Cancer Care: Key Factors in Decision-Making
On the Frontlines of Metastatic Breast Cancer
Navigating Metastatic Breast Cancer Care: Key Factors in Decision-Making
- Paolo Tarantino, MD
Weighing the Environmental Impact of Colorectal Cancer Screening Methods
Weighing the Environmental Impact of Colorectal Cancer Screening Methods
Clinician's Roundtable
Weighing the Environmental Impact of Colorectal Cancer Screening Methods
- Peter Buch, MD, FACG, AGAF, FACP
- A. Mark Fendrick, MD
Reducing Prostate Cancer Cell Production: The Role of Bipolar Androgen Therapy
Reducing Prostate Cancer Cell Production: The Role of Bipolar Androgen Therapy
On the Frontlines of Prostate Cancer
Reducing Prostate Cancer Cell Production: The Role of Bipolar Androgen Therapy
- Mohit Khera, M.D., M.B.A., M.P.H.
MinuteCE®
Chemotherapy Strategies in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
0.25 credits 2 episodes
- Eileen O’Reilly, MD
- Efrat Dotan, MD
0.25 credits 2 episodes
HER2 Testing: The Evolving Role of Immunohistochemistry (IHC)
HER2 Testing: The Evolving Role of Immunohistochemistry (IHC)
CME/CE
HER2 Testing: The Evolving Role of Immunohistochemistry (IHC)
- Fernando López-Ríos, MD, PhD
- Christian Rolfo, MD, PhD
- Charlie Gourley, MD, PhD
Reducing Patient Time Burden in HER2+ Breast Cancer with Subcutaneous Trastuzumab/Pertuzumab
Reducing Patient Time Burden in HER2+ Breast Cancer with Subcutaneous Trastuzumab/Pertuzumab
Project Oncology®
Reducing Patient Time Burden in HER2+ Breast Cancer with Subcutaneous Trastuzumab/Pertuzumab
Prostate Cancer Care: Testosterone Therapy’s Impact on Biochemical Recurrence
Prostate Cancer Care: Testosterone Therapy’s Impact on Biochemical Recurrence
On the Frontlines of Prostate Cancer
Prostate Cancer Care: Testosterone Therapy’s Impact on Biochemical Recurrence
- Mohit Khera, M.D., M.B.A., M.P.H.